Fee Schedule
Effective Monday, August 3, 2020, Cboe will make updates to the Options Regulatory Fees (“ORF”) on the Cboe Options, C2 Options, and BZX Options Exchanges, subject to regulatory review. No change is being proposed for EDGX Options Exchange. Please click the title for complete details.
Overview Applicable Cboe Exchange: Cboe Options Effective Wednesday, July 1, 2020, Cboe will introduce the following pricing changes on Cboe Options, subject to regulatory review.
Overview: Effective Wednesday, July 1, 2020, Cboe will introduce the following pricing changes on the EDGX Options Exchange, subject to regulatory review.
Effective Monday, June 15, 2020, Cboe will introduce the following pricing changes on Cboe Options, subject to regulatory review.
Applicable Cboe Exchange: Cboe BZX Options Effective Monday, June 1, 2020, Cboe will introduce the following pricing changes on the BZX Options Exchange, subject to regulatory review.
Effective Friday, May 1, 2020, Cboe will introduce the following pricing changes on Cboe Options, subject to regulatory review.
Effective Friday, May 1, 2020, Cboe will introduce the following pricing changes on the EDGX Options Exchange, subject to regulatory review.
Effective immediately, TPHs wishing to receive a waiver of fees and applicable surcharges for qualifying electronic compression trades will also be able to mark such orders as compression utilizing the FIX/BOE Compression field, as well as via PULSE and Silexx applications. Please click the title for complete details.
Effective April 7, 2020, all exchange fees and applicable surcharges will be waived for SPX and SPXW compression trades. Please click the title for complete details.
Effective Wednesday, April 1, 2020, Cboe will introduce the following pricing changes on the BZX Options Exchange, subject to regulatory review.
As indicated in a previous notice, as a precaution to reduce large gatherings that can contribute to the spread of the novel coronavirus (COVID-19), Cboe has closed the Cboe Options Exchange (“C1”) trading floor in Chicago effective Monday, March 16, 2020 until further notice. In addition to the previously noted trading floor closure related fee changes, the following changes to C1 fees will also be in effect Wednesday April 1, 2020, subject to regulatory review:
As indicated in a previous notice , Cboe is allowing related future cross (“RFC”) orders to be submitted for VIX index options on the Cboe Options Exchange (“C1”) until further notice. During this time period, the following changes to C1 fees will be in effect, subject to regulatory review. Please click the title for complete details.
Effective on the Cboe Options Exchange for today, Thursday March 19, 2020 only, in the interest of fair and orderly markets the minimum price check for SPX versus SPXW vertical spreads has been updated to -$50.00 and the maximum price check has been updated to $50.00. Click the title for complete details.
As part of a Business Continuity Plan (“BCP”) to back up Nasdaq PHLX floor operations which have been transitioned to electronic only trading, effective Tuesday, March 17, 2020, Cboe Options Exchange (“C1”) began to support FLEX trades in product classes NDX and NDXP. Please click the title for complete details.
As indicated in a previous notice, as a precaution to reduce large gatherings that can contribute to the spread of the novel coronavirus (COVID-19), Cboe has closed the Cboe Options Exchange (“C1”) trading floor in Chicago effective Monday, March 16, 2020 until further notice. During the closure of the trading floor, the following changes to C1 fees will be in effect, subject to regulatory review. Please click the title for complete details.
Effective Monday, March 2, 2020, Cboe will introduce the following pricing changes on the BZX Options Exchange, subject to regulatory review.
Effective Monday, February 3, 2020, Cboe will introduce the following pricing changes on the EDGX Options Exchange, subject to regulatory review.
Effective Monday, February 3, 2020, Cboe will introduce the following pricing changes on the Cboe Options Exchange (“C1”), subject to regulatory review.